Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
RSC Pharmaceutics is Scopus-indexed (Q2, CiteScore 3.8), WoS ESCI, DOAJ. Published by Royal Society of Chemistry.
Checked against the index lists dated .
ISSN 2976-8713Verify ISSN ↗
Publisher: Royal Society of Chemistry
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 15 / 57 | 74th | Q2 |
| Pharmaceutical Science | 86 / 191 | 55th | Q2 |
| Pharmacology | 186 / 328 | 43rd | Q3 |
| Toxicology | 85 / 131 | 35th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q2, CiteScore 3.8.
RSC Pharmaceutics is Q2 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 15 of 57), Q2 in Pharmaceutical Science (rank 86 of 191) and Q3 in Pharmacology (rank 186 of 328), by CiteScore 2025. It is ranked in 4 subject areas in all.
RSC Pharmaceutics is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.8, which places it in quartile Q2 at the 74th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.777, quartile Q1, with an H-index of 12.
RSC Pharmaceutics is published by Royal Society of Chemistry. Its ISSN is 2976-8713.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
RSC Pharmaceutics has an h-index of 23 and a 2-year mean of 6.24 citations per paper (OpenAlex). Its Scopus CiteScore is 3.8, quartile Q2. On 2-year citations it ranks #4 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
RSC Pharmaceutics published 136 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2025–2026), authors are most often from India (28.5%), United States (13%) and United Kingdom (12.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.